Search Results - "Kuhar, Cvetka Grašič"

Clinical and Analytical Validation of Two Methods for Ki-67 Scoring in Formalin Fixed and Paraffin Embedded Tissue Sections of Early Breast Cancer by Đokić, Snežana, Gazić, Barbara, Grčar Kuzmanov, Biljana, Blazina, Jerca, Miceska, Simona, Čugura, Tanja, Grašič Kuhar, Cvetka, Jeruc, Jera

“…Proliferation determined by Ki-67 immunohistochemistry has been proposed as a useful prognostic and predictive marker in breast cancer. However, the clinical…”
Get full text

Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer by Grašič Kuhar, Cvetka, Silvester, Jernej, Mencinger, Marina, Ovčariček, Tanja, Čemažar, Maja, Miceska, Simona, Modic, Živa, Kuhar, Anamarija, Jesenko, Tanja, Kloboves Prevodnik, Veronika

“…Liquid biopsy is becoming an important source of new biomarkers during the treatment of metastatic cancer patients. Using size-based microfluid technology, we…”
Get full text

Application of a 21-Gene Recurrence Score in a Swiss Single-Center Breast Cancer Population: A Comparative Analysis of Treatment Administration before and after TAILORx by Chiru, Elena Diana, Oseledchyk, Anton, Schoetzau, Andreas, Kurzeder, Christian, Mosimann, Raphael, Vetter, Marcus, Grašič Kuhar, Cvetka

“…In patients with hormone receptor positive, human epidermal receptor 2 negative (HR+/HER2-) negative breast cancer (BC), the TAILORx study showed the benefit…”
Get full text

The Possible Role of Anti- and Protumor-Infiltrating Lymphocytes in Pathologic Complete Response in Early Breast Cancer Patients Treated with Neoadjuvant Systemic Therapy by Geršak, Klara, Geršak, Blaž Matija, Gazić, Barbara, Klevišar Ivančič, Andreja, Drev, Primož, Ružić Gorenjec, Nina, Grašič Kuhar, Cvetka

“…The tumor microenvironment, composed of pro- and antitumor immune cells, affects cancer cell behavior. We aimed to evaluate whether tumor-infiltrating…”
Get full text

Mobile App for Symptom Management and Associated Quality of Life During Systemic Treatment in Early Stage Breast Cancer: Nonrandomized Controlled Prospective Cohort Study by Grašič Kuhar, Cvetka, Gortnar Cepeda, Tjaša, Kovač, Timotej, Kukar, Matjaž, Ružić Gorenjec, Nina

“…Providing patients with cancer who are undergoing systemic therapy with useful information about symptom management is essential to prevent unnecessary…”
Get full text

COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information by Mauri, Davide, Kamposioras, Konstantinos, Tsali, Lampriani, Dambrosio, Mario, De Bari, Berardino, Hindi, Nadia, Salembier, Carl, Nixon, Joanna, Dimitrios, Tzachanis, Alongi, Flippo, Hameed, Hassan, Valachis, Antonios, Papadimitriou, Konstantinos, Corradini, Stefanie, Popovic, Lazar, Kopecky, Jindrich, Rodriguez, Andres, Antunac, Katarina, Yi, Junlin, Lovey, Jozsef, Strojan, Primoz, Saraireh, Haytham, Røtterud, Ranveig, Chojnacka, Marzanna, Olalla, Santa Cruz, Chilingirova, Natalia, De Mello, Ramon Andrade, Amaral, Giovanna Araujo, Arbabi, Farsid, Vidra, Radu, Rapushi, Erjeta, Takeuchi, Dan, Christopoulos, Chirstos, Ivanova, Irina, Djan, Igor, Petricevic, Branka, Cellini, Francesco, Mihaylova, Iglika, Plavetic, Natalija Dedic, Kuhar, Cvetka Grašič, Takeuchi, Elena, Kountourakis, Pantelis, Ntellas, Panagiotis, Gazouli, Ioanna, Gkoura, Stefania, Yuce, Salih, Er, Özlem, Yasmina, Chait, Kumaran, Gireesh, Spahiu, Orges, Yusuf, Aasim, Gono, Paulina, Apostolidis, Kathi, Tolia, Maria

“…Covid-19 vaccination has started in the majority of the countries at the global level. Cancer patients are at high risk for infection, serious illness, and…”
Get more information

TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck by Strojan, Primož, Kuhar, Cvetka Grašič, Žumer, Barbara, Kadivec, Maksimilijan, Karner, Katarina, Fajdiga, Igor, Jančar, Boris, Gale, Nina, Poljak, Mario, Kocjan, Boštjan J, Zakotnik, Branko

“…Background The purpose of this study was to assess the efficacy and toxicity of docetaxel, cisplatin/5‐fluorouracil (TPF) induction chemotherapy and…”
Get full text

Biomarkers for Outcome in Metastatic Melanoma in First Line Treatment with Immune Checkpoint Inhibitors by Mesti, Tanja, Grašič Kuhar, Cvetka, Ocvirk, Janja

“…A high proportion of metastatic melanoma patients do not respond to immune checkpoint inhibitors (ICI), and until now, no validated biomarkers for response and…”
Get full text

Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer by Kuhar, Cvetka Grašič, Borštnar, Simona, Gazić, Barbara, Matos, Erika

“…To assess real-world outcomes and prognostic factors of non-metastatic inflammatory breast cancer according to immunohistochemistry (IHC)-based subtype and…”
Get full text

Neuroendocrine Carcinoma of the Larynx and Pharynx: A Clinical and Histopathological Study by Strojan, Primož, Šifrer, Robert, Ferlito, Alfio, Grašič-Kuhar, Cvetka, Lanišnik, Boštjan, Plavc, Gaber, Zidar, Nina

“…Neuroendocrine carcinomas (NECs) of the head and neck are rare and the experience scanty. The Cancer Registry of Slovenia database was used to identify cases…”
Get full text

Prognostic Importance of Axillary Lymph Node Response to Neoadjuvant Systemic Therapy on Axillary Surgery in Breast Cancer-A Single Center Experience by Grašič Kuhar, Cvetka, Geiger, James, Schwab, Fabienne Dominique, Heinzelmann-Schwartz, Viola, Vetter, Marcus, Weber, Walter Paul, Kurzeder, Christian

“…Neoadjuvant systemic treatment (NST) is the standard treatment for HER2+, triple-negative (TN), and highly proliferative luminal HER2- early breast cancer…”
Get full text

Skin Reaction to Cetuximab as a Criterion for Treatment Selection in Head and Neck Cancer by Strojan, Primož, Zakotnik, Branko, Žumer, Barbara, Karner, Katarina, Dremelj, Marta, Jančar, Boris, Jereb, Simona, Grašič-Kuhar, Cvetka

“…It can be hypothesized that in patients with locally advanced head and neck cancer and prominent cetuximab (CMb)-induced skin rash, immunoradiotherapy would…”
Get full text

Changes in the quality of life of early breast cancer patients and comparison with the normative Slovenian population by Grasic Kuhar, Cvetka, Gortnar Cepeda, Tjasa, Kurzeder, Christian, Vetter, Marcus

“…We aimed to identify changes in quality of life after breast cancer treatment and compare them with the normative population data for the Slovenian population…”
Get full text

Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review by Lozar, Taja, Wang, Wei, Gavrielatou, Niki, Christensen, Leslie, Lambert, Paul F, Harari, Paul M, Rimm, David L, Burtness, Barbara, Grasic Kuhar, Cvetka, Carchman, Evie H

“…A growing body of literature suggests that the expression of cytokeratin 17 (K17) correlates with inferior clinical outcomes across various cancer types. In…”
Get full text

Outcome of patients with recurrent/metastatic squamous cell head and neck cancer treated with platinum‑based chemotherapy with or without cetuximab in real‑world practice by Zupancic, Tina, Zakotnik, Branko, Kuhar, Cvetka Grasic

“…Patients with recurrent or metastatic squamous cell head and neck cancer (R/M SCHNC) exhibit a poor prognosis with a median overall survival (OS) time of <1…”
Get full text

Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth by Kamposioras, Konstantinos, Mauri, Davide, Papadimitriou, Konstantinos, Anthoney, Alan, Hindi, Nadia, Petricevic, Branka, Dambrosio, Mario, Valachis, Antonis, Kountourakis, Pantelis, Kopecky, Jindrich, Kuhar, Cvetka Grašič, Popovic, Lazar, Chilingirova, Nataliya P, Zarkavelis, George, de Mello, Ramon Andrade, Plavetić, Natalija Dedić, Christopoulos, Christos, Mostert, Bianca, Goffin, John R, Tzachanis, Dimitiros, Saraireh, Haytham Hamed, Ma, Fei, Pavese, Ida, Tolia, Maria

“…Pandemic COVID-19 is an unexpected challenge for the oncological community, indicating potential detrimental effects on cancer patients. Our aim was to…”
Get full text

Explanation and reliability of prediction models: the case of breast cancer recurrence by Štrumbelj, Erik, Bosnić, Zoran, Kononenko, Igor, Zakotnik, Branko, Grašič Kuhar, Cvetka

“…In this paper, we describe the first practical application of two methods, which bridge the gap between the non-expert user and machine learning models. The…”
Get full text

Efficacy and safety of selective cyclin-dependent kinases 4/6 inhibitors in hormone-receptor-positive, HER2-negative advanced breast cancer – results from a real-world setting by KOVAČ, ANJA, Matos, Erika, Kuhar, Cvetka Grašič, Čakš, Marina, Ovčariček, Tanja, Mencinger, Marina, Humar, Mojca, Borštnar, Simona

“…•This is the first national real-world analysis of CDK inhibitors in Europe.•It proves the clinical benefit of CDK inhibitors no matter the line of systemic…”
Get full text

The biology and clinical potential of circulating tumor cells by Lozar, Taja, Gersak, Klara, Cemazar, Maja, Kuhar, Cvetka Grasic, Jesenko, Tanja

“…Background Tumor cells can shed from the tumor, enter the circulation and travel to distant organs, where they can seed metastases. These cells are called…”
Get full text

Efficacy (and safety) of vaccination against SARS-CoV-2 in cancer patients on active treatment by Tina Zupančič, Cvetka Kuhar Grašič

“…Since the COVID-19 pandemic, cancer patients have been recognized as a group with an increased risk of complications, if they become infected with the…”
Get full text